CA2493010A1 - Uveoscleral drainage device - Google Patents
Uveoscleral drainage device Download PDFInfo
- Publication number
- CA2493010A1 CA2493010A1 CA002493010A CA2493010A CA2493010A1 CA 2493010 A1 CA2493010 A1 CA 2493010A1 CA 002493010 A CA002493010 A CA 002493010A CA 2493010 A CA2493010 A CA 2493010A CA 2493010 A1 CA2493010 A1 CA 2493010A1
- Authority
- CA
- Canada
- Prior art keywords
- shunt
- elongate body
- spaced
- insertion head
- elongate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/00781—Apparatus for modifying intraocular pressure, e.g. for glaucoma treatment
Abstract
An ophthalmic shunt implantable in an eye having an elongate body and a conduit for conducting aqueous humor from an anterior chamber of the eye to the suprachoroidal space of the eye. The elongate body has a forward end and an insertion head that extends from the forward end. The insertion head defines a shearing edge suitable for cutting eye tissue engage thereby. The forward end and the isertion head of the body define a shoulder surface. The conduit has a first end defined on a portion of atop surface of the insertio n head. The conduit also extends through the body from the forward end to a ba ck end thereof. The first end of the conduit is spaced from the shearing edge and, in one example, from the shoulder of The body.
Claims (50)
1. An ophthalmic shunt implantable in an eye, comprising:
an elongate body having a forward end, a spaced back end, and an insertion head extending from the forward end of the elongate body, the insertion head having a top surface and defining a shearing edge constructed and arranged for cutting eye tissue engaged thereby, the body having a substantially fusiform cross-sectional shape, the forward end and the insertion head of said body further defining a shoulder surface; and a conduit having a first end defined on a portion of the top surface of said insertion head and extending through said body from the forward end to the back end thereof, the first end being spaced from the shearing edge and the shoulder surface of said body.
an elongate body having a forward end, a spaced back end, and an insertion head extending from the forward end of the elongate body, the insertion head having a top surface and defining a shearing edge constructed and arranged for cutting eye tissue engaged thereby, the body having a substantially fusiform cross-sectional shape, the forward end and the insertion head of said body further defining a shoulder surface; and a conduit having a first end defined on a portion of the top surface of said insertion head and extending through said body from the forward end to the back end thereof, the first end being spaced from the shearing edge and the shoulder surface of said body.
2. The shunt of Claim 1, wherein the elongate body has a lower surface, and wherein a portion of the insertion head is substantially co-planar to the lower surface thereof.
3. The shunt of Claim 1, wherein the elongate body has an arcuate shape along at least a portion of its length that is adapted to extend along the curvature of the sclera.
4. The shunt of Claim 1, wherein the elongate body has an upper surface and a spaced lower surface, and wherein at lease one planar surface constructed and arranged for grasping by a surgical tool is defined on at least a portion of at least one of the respective upper and lower surfaces of the elongate body.
5. The shunt of Claim 1, wherein the elongate body has a longitudinal axis, and wherein a longitudinally extending groove constructed and arranged for grasping by a surgical tool is defined on at least a portion of an exterior surface of the elongate body.
6. The shunt of Claim 5, wherein the elongate body has an upper surface and a spaced lower surface, and wherein the longitudinally extending groove is defined on at least a portion of the upper surface of the elongate body.
7. The shunt of Claim 6, wherein a planar surface constructed and arranged for grasping by the surgical tool is defined on at least a portion of the lower surface of the elongate body.
8. The shunt of Claim 6, wherein a second longitudinally extending groove constructed and arranged for grasping by the surgical tool is defined on at least a portion of the lower surface of the elongate body.
9. The shunt of Claim 1, wherein the first end of the conduit is positioned at an acute angle with respect to the top surface of the insertion head.
10. The shunt of Claim 1, wherein the elongate body is substantially rigid.
11. The shunt of Claim 1, wherein the elongate body is comprised of biocompatible materials.
12. The shunt of Claim 1, wherein an exterior surface of the elongate body is non-porous.
13. The shunt of Claim 1, wherein the elongate body has a first elongate edge and a spaced second elongate edge, and wherein said body has at least a pair of spaced notches constructed and arranged for facilitating suturing the elongate body to eye tissue, one notch of the pair of spaced notches being defined in each respective elongate edge.
14. The shunt of Claim 1, wherein the elongate body has an upper surface and a spaced lower surface, and wherein the body has at least a pair of spaced bores extending between the upper and lower surfaces of said body, the pair of spaced bores constructed and arranged for facilitating suturing the elongate body to eye tissue.
15. The shunt of Claim 1, wherein the conduit comprises a wicking member constructed and arranged for regulating the flow of aqueous humor from an inlet end to an outlet end of the wicking member.
16. The shunt of Claim 1, further comprising a wicking member constructed and arranged for regulating the flow of aqueous humor from an inlet end to an outlet end of the wicking member, the wicking member disposed within at least a portion of the conduit.
17. An ophthalmic shunt implantable in an eye, comprising:
a thin elongate body of a biocompatible material, the body having a forward end, a spaced back end, and a substantially fusiform cross-sectional shape, said body further comprising an insertion head extending from the forward end of the elongate body, the insertion head having a top surface and defining a shearing edge constructed and arranged for cutting eye tissue engaged thereby, the shearing edge having a substantially arcuate shape, the forward end and the insertion head of said body further defining a shoulder surface; and a conduit defined on a portion of the top surface of said insertion head and extending through said body from the forward end to the back end thereof, the conduit having a first end that is spaced from the shearing edge.
a thin elongate body of a biocompatible material, the body having a forward end, a spaced back end, and a substantially fusiform cross-sectional shape, said body further comprising an insertion head extending from the forward end of the elongate body, the insertion head having a top surface and defining a shearing edge constructed and arranged for cutting eye tissue engaged thereby, the shearing edge having a substantially arcuate shape, the forward end and the insertion head of said body further defining a shoulder surface; and a conduit defined on a portion of the top surface of said insertion head and extending through said body from the forward end to the back end thereof, the conduit having a first end that is spaced from the shearing edge.
18. The shunt of Claim 17, wherein the insertion head has a base portion having a first width, wherein the elongate body has a first elongate edge and a spaced second elongate edge, and wherein the first and second elongate edges are spaced a second width that is greater than said first width.
19. The shunt of Claim 17, wherein the elongate body has a lower surface, and wherein a portion of the insertion head is substantially co-planar to the lower surface thereof.
20. The shunt of Claim 17, wherein the elongate body has an arcuate shape along at least a portion of its length that is adapted to extend along the curvature of the sclera.
21. The shunt of Claim 17, wherein the elongate body has an upper surface and a spaced lower surface, and wherein at least one planar surface constructed and arranged for grasping by a surgical tool is defined on at least a portion of at least one of the respective upper and lower surfaces of the elongate body.
22. The shunt of Claim 17, wherein the elongate body has a longitudinal axis, and wherein a longitudinally extending groove constructed and arranged for grasping by a surgical tool is defined on at least a portion of an exterior surface of the elongate body.
23. The shunt of Claim 22, wherein the elongate body has an upper surface and a spaced lower surface, and wherein the longitudinally extending groove is defined on at least a portion of the upper surface of the elongate body.
24. The shunt of Claim 23, wherein a planar surface constructed and arranged for grasping by the surgical tool is defined on at least a portion of the lower surface of the elongate body.
25. The shunt of Claim 23, wherein a second longitudinally extending groove is defined on at least a portion of the lower surface of the elongate body.
26. The shunt of Claim 17, wherein an exterior surface of the elongate body is non-porous.
27. The shunt of Claim 17, wherein the elongate body has a first elongate edge and a spaced second elongate edge, and wherein said body has at least a pair of spaced notches constructed and arranged for facilitating suturing the elongate body to eye tissue, one notch of the pair of spaced notches being defined in each respective elongate edge.
28. The shunt of Claim 17, wherein the elongate body has an upper surface and a spaced lower surface, and wherein the body has at least a pair of spaced bores extending between the upper and lower surfaces of said body, the pair of spaced bores constructed and arranged for facilitating suturing the elongate body to eye tissue.
29. The shunt of Claim 17, wherein the elongate body has a length of such extent to extend from proximate the anterior chamber of the eye to the suprachoroidal space.
30. The shunt of Claim 17, wherein the conduit comprises a wicking member constructed and arranged for regulating the flow of aqueous humor from an inlet end to an outlet end of the wicking member.
31. The shunt of Claim 17, further comprising a wicking member constructed and arranged for regulating the flow of aqueous humor from an inlet end to an outlet end of the wicking member, the wicking member disposed within at least a portion of the conduit.
32. An ophthalmic shunt implantable in an eye, comprising:
a thin elongate body of biocompatible material, the body having a longitudinal axis, a forward end, a spaced back end, and a substantially fusiform cross-sectional shape, the body further comprising an insertion head extending from the forward end of the elongate body, the insertion head having a top surface and defining a shearing edge constructed and arranged for cutting eye tissue engaged thereby, the body defining a longitudinally extending bore, a proximal end of the bore defined in the forward end of the body, the proximal end positioned adjacent a portion of the top surface of the insertion head, the forward end and the insertion head of said body further defining a shoulder surface; and a tube of biocompatible material, the tube having a first end and a spaced second end, at least a portion of the tube positioned within the bore of said body such that the second end of the tube is adjacent a distal end of the bore of said body and such that the first end of the tube extends through the proximal end of the bore and overlies a portion of the top surface of the insertion head, the first end of the tube being spaced from the shearing edge and the shoulder surface of said body.
a thin elongate body of biocompatible material, the body having a longitudinal axis, a forward end, a spaced back end, and a substantially fusiform cross-sectional shape, the body further comprising an insertion head extending from the forward end of the elongate body, the insertion head having a top surface and defining a shearing edge constructed and arranged for cutting eye tissue engaged thereby, the body defining a longitudinally extending bore, a proximal end of the bore defined in the forward end of the body, the proximal end positioned adjacent a portion of the top surface of the insertion head, the forward end and the insertion head of said body further defining a shoulder surface; and a tube of biocompatible material, the tube having a first end and a spaced second end, at least a portion of the tube positioned within the bore of said body such that the second end of the tube is adjacent a distal end of the bore of said body and such that the first end of the tube extends through the proximal end of the bore and overlies a portion of the top surface of the insertion head, the first end of the tube being spaced from the shearing edge and the shoulder surface of said body.
33. The shunt of Claim 32, wherein the shearing edge has a substantially arcuate shape.
34. An ophthalmic shunt implantable in an eye, comprising:
a thin elongate body of biocompatible material, the body having a longitudinal axis, an upper surface, a forward end, a spaced back end, and an insertion head extending from the forward end of the elongate body, the insertion head having a top surface and defining a shearing edge constructed and arranged for cutting eye tissue engaged thereby, the upper surface of the body defining a longitudinally extending slit, the forward end and the insertion head of said body further defining a shoulder surface; and a wicking member having an inlet end and an outlet end, the wicking member constructed and arranged for regulating the flow of aqueous humor from the inlet end to the outlet end and for positioning within at least a portion of the slit of said body and overlying a portion of the top surface of the insertion head, the inlet end of the wicking member being spaced from the shearing edge of said body.
a thin elongate body of biocompatible material, the body having a longitudinal axis, an upper surface, a forward end, a spaced back end, and an insertion head extending from the forward end of the elongate body, the insertion head having a top surface and defining a shearing edge constructed and arranged for cutting eye tissue engaged thereby, the upper surface of the body defining a longitudinally extending slit, the forward end and the insertion head of said body further defining a shoulder surface; and a wicking member having an inlet end and an outlet end, the wicking member constructed and arranged for regulating the flow of aqueous humor from the inlet end to the outlet end and for positioning within at least a portion of the slit of said body and overlying a portion of the top surface of the insertion head, the inlet end of the wicking member being spaced from the shearing edge of said body.
35. The shunt of Claim 34, wherein the shearing edge has a substantially arcuate shape.
36. The shunt of Claim 34, wherein the body has a substantially fusiform cross-sectional shape.
37. The shunt of Claim 34, wherein the elongate body has a lower surface, and wherein at least one planar surface constructed and arranged for grasping by a surgical tool is defined on at least a portion of at least one of the respective upper and lower surfaces of the elongate body.
38 The shunt of Claim 37, wherein one planar surface is defined in a portion of the slit of said body.
39. The shunt of Claim 34, wherein the elongate body has a longitudinal axis, and wherein a longitudinally extending groove constructed and arranged for grasping by a surgical tool is defined on at least a portion of an exterior surface of the elongate body.
40. The shunt of Claim 34, wherein an exterior surface of the elongate body is non-porous.
41. The shunt of Claim 34, wherein the elongate body has a first elongate edge and a spaced second elongate edge, and wherein said body has at least a pair of spaced notches constructed and arranged for facilitating suturing the elongate body to eye tissue, one notch of the pair of spaced notches being defined in each respective elongate edge.
42. The shunt of Claim 34, wherein the elongate body has a lower surface, and wherein the body has at least a pair of spaced bores extending between the upper and lower surfaces of said body, the pair of spaced bores constructed and arranged for facilitating suturing the elongate body to eye tissue.
43. The shunt of Claim 34, wherein the elongate body has a length of such extent to extend from proximate the anterior chamber of the eye to the suprachoroidal space.
44. A method for lowering eye pressure in an eye, comprising:
a. making a first incision in and through the conjunctiva and the sclera at a position posterior to the limbus;
b. providing a biocompatible ophthalmic shunt comprising:
i. an elongate body having a forward end, a spaced back end, and an insertion head extending from the forward end of the elongate body, the insertion head having a top surface and defining a shearing edge constructed and arranged for cutting eye tissue engaged thereby, the forward end and the insertion head of said body defining a shoulder surface; and ii. a conduit having a first end defined on a portion of the top surface of said insertion head and extending through said body from the forward end to the back end thereof, the first end being spaced from the shearing edge and the shoulder surface of said body, c. grasping a portion of the elongate body of the shunt;
d. disposing the insertion head of the shunt in and through the first incision and into the supracilliary space of the eye;
e. inserting at least a portion of the shearing edge of the insertion head of the shunt into and through the anterior chamber angle and into the anterior chamber of the eye so that the first end of the conduit is in fluid communication with the anterior chamber; and f. suturing the first incision closed.
a. making a first incision in and through the conjunctiva and the sclera at a position posterior to the limbus;
b. providing a biocompatible ophthalmic shunt comprising:
i. an elongate body having a forward end, a spaced back end, and an insertion head extending from the forward end of the elongate body, the insertion head having a top surface and defining a shearing edge constructed and arranged for cutting eye tissue engaged thereby, the forward end and the insertion head of said body defining a shoulder surface; and ii. a conduit having a first end defined on a portion of the top surface of said insertion head and extending through said body from the forward end to the back end thereof, the first end being spaced from the shearing edge and the shoulder surface of said body, c. grasping a portion of the elongate body of the shunt;
d. disposing the insertion head of the shunt in and through the first incision and into the supracilliary space of the eye;
e. inserting at least a portion of the shearing edge of the insertion head of the shunt into and through the anterior chamber angle and into the anterior chamber of the eye so that the first end of the conduit is in fluid communication with the anterior chamber; and f. suturing the first incision closed.
45. The method of Claim 44, further comprising suturing the implant to a portion of the sclera.
46. The method of Claim 44, further comprising, prior to suturing the first incision closed, forcing the insertion head anteriorally to seat the shoulder surface of the implant adjacent an interior surface of the supraciliary space of the eye.
47. A method for treating glaucoma in an eye, comprising:
a. providing a biocompatible ophthalmic shunt comprising:
i. a thin elongate body of a biocompatible material, the body having a forward end, a spaced back end, and a substantially fusiform cross-sectional shape, said body further comprising an insertion head extending from the forward end of the elongate body, the insertion head having a top surface and defining a shearing edge constructed and arranged for cutting eye tissue engaged thereby, the shearing edge having a substantially arcuate shape, the forward end and the insertion head of said body defining a shoulder surface; and ii. a conduit defined on a portion of the top surface of said insertion head and extending through said body from the forward end to the back end thereof, the conduit having a first end that is spaced from the shearing edge and the shoulder surface of said body, b. inserting at least a portion of the shearing edge of the insertion head of the shunt into and through the anterior chamber angle and into the anterior chamber of the eye;
disposing the first end of the conduit into fluid communication with the anterior chamber of the eye;
d. disposing the back end of the elongate body of the shunt into the suprachoroidal space of the eye so that a second end of the conduit is in fluid communication with the suprachoroidal space; and d. securing the shunt to the eye by suturing a portion of the elongate body to the eye.
a. providing a biocompatible ophthalmic shunt comprising:
i. a thin elongate body of a biocompatible material, the body having a forward end, a spaced back end, and a substantially fusiform cross-sectional shape, said body further comprising an insertion head extending from the forward end of the elongate body, the insertion head having a top surface and defining a shearing edge constructed and arranged for cutting eye tissue engaged thereby, the shearing edge having a substantially arcuate shape, the forward end and the insertion head of said body defining a shoulder surface; and ii. a conduit defined on a portion of the top surface of said insertion head and extending through said body from the forward end to the back end thereof, the conduit having a first end that is spaced from the shearing edge and the shoulder surface of said body, b. inserting at least a portion of the shearing edge of the insertion head of the shunt into and through the anterior chamber angle and into the anterior chamber of the eye;
disposing the first end of the conduit into fluid communication with the anterior chamber of the eye;
d. disposing the back end of the elongate body of the shunt into the suprachoroidal space of the eye so that a second end of the conduit is in fluid communication with the suprachoroidal space; and d. securing the shunt to the eye by suturing a portion of the elongate body to the eye.
48. The method of Claim 47, wherein the shunt is sutured to a portion of the sclera.
49. The method of Claim 47, further comprising introducing the insertion head anteriorally to seat the shoulder surface of the implant adjacent an interior surface of the supraciliary space of the eye.
50. The method of Claim 47, further comprising, prior to the insertion of the insertion head into the anterior chamber making a first incision in and through the conjunctiva and the sclera at a position posterior to the limbus.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2744117A CA2744117A1 (en) | 2002-07-19 | 2003-07-21 | Uveoscleral drainage device |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US39756502P | 2002-07-19 | 2002-07-19 | |
US60/397,565 | 2002-07-19 | ||
PCT/US2003/022832 WO2004008945A2 (en) | 2002-07-19 | 2003-07-21 | Uveoscleral drainage device |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2744117A Division CA2744117A1 (en) | 2002-07-19 | 2003-07-21 | Uveoscleral drainage device |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2493010A1 true CA2493010A1 (en) | 2004-01-29 |
CA2493010C CA2493010C (en) | 2011-09-13 |
Family
ID=30771081
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2744117A Abandoned CA2744117A1 (en) | 2002-07-19 | 2003-07-21 | Uveoscleral drainage device |
CA2493010A Expired - Fee Related CA2493010C (en) | 2002-07-19 | 2003-07-21 | Uveoscleral drainage device |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2744117A Abandoned CA2744117A1 (en) | 2002-07-19 | 2003-07-21 | Uveoscleral drainage device |
Country Status (13)
Country | Link |
---|---|
US (2) | US7041077B2 (en) |
EP (3) | EP1534363B1 (en) |
CN (2) | CN100591372C (en) |
AT (2) | ATE419026T1 (en) |
AU (1) | AU2003256657A1 (en) |
BR (1) | BR0312816A (en) |
CA (2) | CA2744117A1 (en) |
DE (1) | DE60325606D1 (en) |
ES (1) | ES2320121T3 (en) |
HK (1) | HK1084313A1 (en) |
MX (1) | MXPA05000807A (en) |
WO (1) | WO2004008945A2 (en) |
ZA (1) | ZA200501458B (en) |
Families Citing this family (143)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8313454B2 (en) | 1997-11-20 | 2012-11-20 | Optonol Ltd. | Fluid drainage device, delivery device, and associated methods of use and manufacture |
US6203513B1 (en) | 1997-11-20 | 2001-03-20 | Optonol Ltd. | Flow regulating implant, method of manufacture, and delivery device |
AU767526B2 (en) | 1999-04-26 | 2003-11-13 | Gmp Vision Solutions, Inc. | Trabeculotomy device and method for treating glaucoma |
US20050119737A1 (en) * | 2000-01-12 | 2005-06-02 | Bene Eric A. | Ocular implant and methods for making and using same |
US6638239B1 (en) | 2000-04-14 | 2003-10-28 | Glaukos Corporation | Apparatus and method for treating glaucoma |
US7708711B2 (en) | 2000-04-14 | 2010-05-04 | Glaukos Corporation | Ocular implant with therapeutic agents and methods thereof |
EP2944648B1 (en) | 2001-03-29 | 2019-11-13 | Bausch Health Ireland Limited | Guanylate cyclase receptor agonists for the treatment of organ inflammation |
US7431710B2 (en) | 2002-04-08 | 2008-10-07 | Glaukos Corporation | Ocular implants with anchors and methods thereof |
US7488303B1 (en) * | 2002-09-21 | 2009-02-10 | Glaukos Corporation | Ocular implant with anchor and multiple openings |
EP1418868B1 (en) | 2001-04-07 | 2008-03-26 | Glaukos Corporation | Glaucoma stent for glaucoma treatment |
US7678065B2 (en) | 2001-05-02 | 2010-03-16 | Glaukos Corporation | Implant with intraocular pressure sensor for glaucoma treatment |
US7951155B2 (en) | 2002-03-15 | 2011-05-31 | Glaukos Corporation | Combined treatment for cataract and glaucoma treatment |
US9301875B2 (en) | 2002-04-08 | 2016-04-05 | Glaukos Corporation | Ocular disorder treatment implants with multiple opening |
CN100591372C (en) | 2002-07-19 | 2010-02-24 | 耶鲁大学 | Uveoscleral drainage device |
EP1539066B1 (en) * | 2002-09-17 | 2012-11-07 | Iscience Surgical Corporation | Apparatus surgical bypass of aqueous humor |
US20040225250A1 (en) * | 2003-05-05 | 2004-11-11 | Michael Yablonski | Internal shunt and method for treating glaucoma |
CA2529495C (en) * | 2003-06-16 | 2013-02-05 | Solx, Inc. | Shunt for the treatment of glaucoma |
US7291125B2 (en) * | 2003-11-14 | 2007-11-06 | Transcend Medical, Inc. | Ocular pressure regulation |
US7282046B2 (en) | 2004-01-22 | 2007-10-16 | Peter M. Adams, Doug P. Adams, and John Sullivan, Collectively as the Stockholder Representative Committee | Glaucoma treatment method |
US20060036207A1 (en) * | 2004-02-24 | 2006-02-16 | Koonmen James P | System and method for treating glaucoma |
US20060219627A1 (en) * | 2005-03-31 | 2006-10-05 | Rodgers M S | MEMS filter module with concentric filtering walls |
US20060173399A1 (en) * | 2005-02-01 | 2006-08-03 | Rodgers M S | MEMS flow module with pivoting-type baffle |
US20050194303A1 (en) * | 2004-03-02 | 2005-09-08 | Sniegowski Jeffry J. | MEMS flow module with filtration and pressure regulation capabilities |
US7544176B2 (en) * | 2005-06-21 | 2009-06-09 | Becton, Dickinson And Company | Glaucoma implant having MEMS flow module with flexing diaphragm for pressure regulation |
US7364564B2 (en) * | 2004-03-02 | 2008-04-29 | Becton, Dickinson And Company | Implant having MEMS flow module with movable, flow-controlling baffle |
US7226540B2 (en) * | 2004-02-24 | 2007-06-05 | Becton, Dickinson And Company | MEMS filter module |
US7384550B2 (en) * | 2004-02-24 | 2008-06-10 | Becton, Dickinson And Company | Glaucoma implant having MEMS filter module |
US20060206049A1 (en) * | 2005-03-14 | 2006-09-14 | Rodgers M S | MEMS flow module with piston-type pressure regulating structure |
CA2564806A1 (en) * | 2004-04-29 | 2005-11-17 | Iscience Surgical Corporation | Apparatus and method for surgical enhancement of aqueous humor drainage |
US20100173866A1 (en) * | 2004-04-29 | 2010-07-08 | Iscience Interventional Corporation | Apparatus and method for ocular treatment |
US7862531B2 (en) * | 2004-06-25 | 2011-01-04 | Optonol Ltd. | Flow regulating implants |
AU2011253724B2 (en) * | 2004-06-25 | 2013-08-29 | Alcon Inc. | Flow regulating implants |
AR054647A1 (en) | 2005-02-21 | 2007-07-11 | Maldonado Bas Arturo | DEVICE FOR WATER HUMOR DRAINAGE IN GLAUCOMA CASES |
EP3632385A1 (en) * | 2006-01-17 | 2020-04-08 | Novartis AG | Glaucoma treatment device |
US9084662B2 (en) * | 2006-01-17 | 2015-07-21 | Transcend Medical, Inc. | Drug delivery treatment device |
AU2016201445B2 (en) * | 2006-01-17 | 2017-10-26 | Alcon Inc. | Glaucoma treatment device |
US10085884B2 (en) | 2006-06-30 | 2018-10-02 | Aquesys, Inc. | Intraocular devices |
US8801766B2 (en) | 2010-11-15 | 2014-08-12 | Aquesys, Inc. | Devices for deploying intraocular shunts |
US8852256B2 (en) | 2010-11-15 | 2014-10-07 | Aquesys, Inc. | Methods for intraocular shunt placement |
EP2043572B1 (en) | 2006-06-30 | 2014-12-31 | Aquesys Inc. | Apparatus for relieving pressure in an organ |
US8663303B2 (en) | 2010-11-15 | 2014-03-04 | Aquesys, Inc. | Methods for deploying an intraocular shunt from a deployment device and into an eye |
US8974511B2 (en) | 2010-11-15 | 2015-03-10 | Aquesys, Inc. | Methods for treating closed angle glaucoma |
US8308701B2 (en) | 2010-11-15 | 2012-11-13 | Aquesys, Inc. | Methods for deploying intraocular shunts |
US8828070B2 (en) | 2010-11-15 | 2014-09-09 | Aquesys, Inc. | Devices for deploying intraocular shunts |
US8721702B2 (en) | 2010-11-15 | 2014-05-13 | Aquesys, Inc. | Intraocular shunt deployment devices |
US9095411B2 (en) | 2010-11-15 | 2015-08-04 | Aquesys, Inc. | Devices for deploying intraocular shunts |
US8852137B2 (en) | 2010-11-15 | 2014-10-07 | Aquesys, Inc. | Methods for implanting a soft gel shunt in the suprachoroidal space |
US8758290B2 (en) | 2010-11-15 | 2014-06-24 | Aquesys, Inc. | Devices and methods for implanting a shunt in the suprachoroidal space |
US20120123316A1 (en) | 2010-11-15 | 2012-05-17 | Aquesys, Inc. | Intraocular shunts for placement in the intra-tenon's space |
US20120123317A1 (en) * | 2010-11-15 | 2012-05-17 | Aquesys, Inc. | Methods for implanation of glaucoma shunts |
BRPI0715467A2 (en) * | 2006-07-11 | 2013-03-12 | Refocus Group Inc | scleral prosthesis for treatment of presbyopia and other eye diseases and related device and methods |
US8911496B2 (en) | 2006-07-11 | 2014-12-16 | Refocus Group, Inc. | Scleral prosthesis for treating presbyopia and other eye disorders and related devices and methods |
AU2013206830B2 (en) * | 2006-07-11 | 2015-09-24 | Refocus Group, Inc. | Scleral prosthesis for treating presbyopia and other eye disorders and related devices and methods |
US8506515B2 (en) | 2006-11-10 | 2013-08-13 | Glaukos Corporation | Uveoscleral shunt and methods for implanting same |
CA2688161C (en) | 2007-06-04 | 2020-10-20 | Kunwar Shailubhai | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
WO2008154502A1 (en) * | 2007-06-07 | 2008-12-18 | Yale University | Uveoscleral drainage device |
WO2009012406A1 (en) * | 2007-07-17 | 2009-01-22 | Transcend Medical, Inc. | Ocular implant with hydrogel expansion capabilities reference to priority document |
US20170360609A9 (en) | 2007-09-24 | 2017-12-21 | Ivantis, Inc. | Methods and devices for increasing aqueous humor outflow |
US7740604B2 (en) | 2007-09-24 | 2010-06-22 | Ivantis, Inc. | Ocular implants for placement in schlemm's canal |
US20090082862A1 (en) | 2007-09-24 | 2009-03-26 | Schieber Andrew T | Ocular Implant Architectures |
US8734377B2 (en) | 2007-09-24 | 2014-05-27 | Ivantis, Inc. | Ocular implants with asymmetric flexibility |
US8512404B2 (en) | 2007-11-20 | 2013-08-20 | Ivantis, Inc. | Ocular implant delivery system and method |
US8808222B2 (en) | 2007-11-20 | 2014-08-19 | Ivantis, Inc. | Methods and apparatus for delivering ocular implants into the eye |
US8109896B2 (en) * | 2008-02-11 | 2012-02-07 | Optonol Ltd. | Devices and methods for opening fluid passageways |
EP2092916A1 (en) | 2008-02-19 | 2009-08-26 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | A method of treating an ocular pathology by applying high intensity focused ultrasound and device thereof |
US9517359B2 (en) | 2009-02-18 | 2016-12-13 | Eye Tech Care | High intensity focused ultrasound device with a concave segment shaped transducer for eye treatment |
AU2009221859B2 (en) | 2008-03-05 | 2013-04-18 | Alcon Inc. | Methods and apparatus for treating glaucoma |
WO2009149278A1 (en) | 2008-06-04 | 2009-12-10 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
ES2522968T3 (en) | 2008-06-04 | 2014-11-19 | Synergy Pharmaceuticals Inc. | Guanylate cyclase agonists useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
EP3298995A1 (en) | 2008-06-25 | 2018-03-28 | Novartis AG | Ocular implant with shape change capabilities |
ES2624828T3 (en) | 2008-07-16 | 2017-07-17 | Synergy Pharmaceuticals Inc. | Guanylate cyclase agonists useful for the treatment of gastrointestinal disorders, inflammation, cancer and others |
US20100056977A1 (en) * | 2008-08-26 | 2010-03-04 | Thaddeus Wandel | Trans-corneal shunt and method |
CN102292050A (en) * | 2008-11-19 | 2011-12-21 | 瑞福克斯集团公司 | Artificial intraocular lens, altered natural crystalline lens, or refilled natural crystalline lens capsule with one or more scleral prostheses for improved performance |
ES2608050T3 (en) | 2008-12-03 | 2017-04-05 | Synergy Pharmaceuticals Inc. | Guanylate cyclase C agonist formulations and methods of use |
AU2009322146B2 (en) | 2008-12-05 | 2015-05-28 | Alcon Inc. | Methods and apparatus for delivering ocular implants into the eye |
US8425473B2 (en) * | 2009-01-23 | 2013-04-23 | Iscience Interventional Corporation | Subretinal access device |
US20100191177A1 (en) * | 2009-01-23 | 2010-07-29 | Iscience Interventional Corporation | Device for aspirating fluids |
JP5524983B2 (en) | 2009-01-28 | 2014-06-18 | トランセンド・メディカル・インコーポレイテッド | Implant system |
US10206813B2 (en) | 2009-05-18 | 2019-02-19 | Dose Medical Corporation | Implants with controlled drug delivery features and methods of using same |
EP2451375B1 (en) | 2009-07-09 | 2018-10-03 | Ivantis, Inc. | Single operator device for delivering an ocular implant |
CN102481404B (en) | 2009-07-09 | 2014-03-05 | 伊万提斯公司 | Ocular implants |
CA2774610A1 (en) * | 2009-09-21 | 2011-03-24 | Vidus Ocular, Inc. | Uveoscleral drainage device |
CN102647960A (en) | 2009-10-23 | 2012-08-22 | 伊万提斯公司 | Ocular implant system and method |
US20110105990A1 (en) * | 2009-11-04 | 2011-05-05 | Silvestrini Thomas A | Zonal drug delivery device and method |
US8529492B2 (en) | 2009-12-23 | 2013-09-10 | Trascend Medical, Inc. | Drug delivery devices and methods |
WO2011083358A1 (en) | 2010-01-11 | 2011-07-14 | Eye Tech Care | Device for treating an ocular pathology by applying doses of laser energy |
US9510973B2 (en) | 2010-06-23 | 2016-12-06 | Ivantis, Inc. | Ocular implants deployed in schlemm's canal of the eye |
US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
CA2810243C (en) | 2010-09-15 | 2021-04-20 | Synergy Pharmaceuticals Inc. | Formulations of guanylate cyclase c agonists and methods of use |
US8585629B2 (en) | 2010-11-15 | 2013-11-19 | Aquesys, Inc. | Systems for deploying intraocular shunts |
US10842671B2 (en) | 2010-11-15 | 2020-11-24 | Aquesys, Inc. | Intraocular shunt placement in the suprachoroidal space |
US9668915B2 (en) | 2010-11-24 | 2017-06-06 | Dose Medical Corporation | Drug eluting ocular implant |
JP6009463B2 (en) | 2011-02-04 | 2016-10-19 | フォーサイト・ビジョン6・インコーポレイテッドForsight Vision6, Inc. | Adjustable intraocular lens |
US10245178B1 (en) | 2011-06-07 | 2019-04-02 | Glaukos Corporation | Anterior chamber drug-eluting ocular implant |
US8657776B2 (en) | 2011-06-14 | 2014-02-25 | Ivantis, Inc. | Ocular implants for delivery into the eye |
EP3659495B1 (en) | 2011-09-13 | 2022-12-14 | Dose Medical Corporation | Intraocular physiological sensor |
US9808373B2 (en) | 2013-06-28 | 2017-11-07 | Aquesys, Inc. | Intraocular shunt implantation |
US8765210B2 (en) | 2011-12-08 | 2014-07-01 | Aquesys, Inc. | Systems and methods for making gelatin shunts |
US8852136B2 (en) | 2011-12-08 | 2014-10-07 | Aquesys, Inc. | Methods for placing a shunt into the intra-scleral space |
US9610195B2 (en) | 2013-02-27 | 2017-04-04 | Aquesys, Inc. | Intraocular shunt implantation methods and devices |
US10080682B2 (en) | 2011-12-08 | 2018-09-25 | Aquesys, Inc. | Intrascleral shunt placement |
US8663150B2 (en) | 2011-12-19 | 2014-03-04 | Ivantis, Inc. | Delivering ocular implants into the eye |
US9101444B2 (en) | 2012-01-12 | 2015-08-11 | Innfocus, Inc. | Method, surgical kit and device for treating glaucoma |
CN103284831A (en) * | 2012-02-29 | 2013-09-11 | 北京大学第三医院 | Foldable glaucoma aqueous humor drainage device |
US9358156B2 (en) | 2012-04-18 | 2016-06-07 | Invantis, Inc. | Ocular implants for delivery into an anterior chamber of the eye |
US10085633B2 (en) | 2012-04-19 | 2018-10-02 | Novartis Ag | Direct visualization system for glaucoma treatment |
US9241832B2 (en) | 2012-04-24 | 2016-01-26 | Transcend Medical, Inc. | Delivery system for ocular implant |
US8888734B2 (en) | 2012-06-05 | 2014-11-18 | Alcon Research, Ltd. | Functionally graded material tube and method for use of the same in implantation |
EP2895123B1 (en) | 2012-09-17 | 2017-06-07 | Novartis Ag | Expanding ocular implant devices |
WO2014078288A1 (en) | 2012-11-14 | 2014-05-22 | Transcend Medical, Inc. | Flow promoting ocular implant |
US10617558B2 (en) | 2012-11-28 | 2020-04-14 | Ivantis, Inc. | Apparatus for delivering ocular implants into an anterior chamber of the eye |
US9125723B2 (en) | 2013-02-19 | 2015-09-08 | Aquesys, Inc. | Adjustable glaucoma implant |
US10159600B2 (en) | 2013-02-19 | 2018-12-25 | Aquesys, Inc. | Adjustable intraocular flow regulation |
US9730638B2 (en) | 2013-03-13 | 2017-08-15 | Glaukos Corporation | Intraocular physiological sensor |
EP2970384A1 (en) | 2013-03-15 | 2016-01-20 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
US9592151B2 (en) | 2013-03-15 | 2017-03-14 | Glaukos Corporation | Systems and methods for delivering an ocular implant to the suprachoroidal space within an eye |
US9987163B2 (en) | 2013-04-16 | 2018-06-05 | Novartis Ag | Device for dispensing intraocular substances |
BR122020011777B1 (en) | 2013-11-14 | 2022-01-25 | AqueSys, Inc | Insertion device for the treatment of glaucoma |
AU2015266850B2 (en) | 2014-05-29 | 2019-12-05 | Glaukos Corporation | Implants with controlled drug delivery features and methods of using same |
US9925088B2 (en) * | 2014-06-06 | 2018-03-27 | Janssen Biotech, Inc. | Sub-retinal tangential needle catheter guide and introducer |
PE20151266A1 (en) * | 2014-07-01 | 2015-09-10 | Velasquez Mario Eduardo Miranda | DRAINAGE DEVICE FOR THE CONTROL OF INTRAOCULAR PRESSURE IN GLAUCOMA |
US10709547B2 (en) | 2014-07-14 | 2020-07-14 | Ivantis, Inc. | Ocular implant delivery system and method |
US10219936B2 (en) * | 2014-09-11 | 2019-03-05 | Orbit Biomedical Limited | Therapeutic agent delivery device with advanceable cannula and needle |
FR3034308B1 (en) * | 2015-03-31 | 2022-01-21 | Philippe Sourdille | OPHTHALMOLOGICAL INTERPOSITION IMPLANT |
FR3034320B1 (en) | 2015-03-31 | 2017-04-28 | Eye Tech Care | ULTRASOUND TREATMENT OCULAR PROBE |
NZ737997A (en) | 2015-06-03 | 2019-03-29 | Aquesys Inc | Ab externo intraocular shunt placement |
JP6837475B2 (en) | 2015-08-14 | 2021-03-03 | イバンティス インコーポレイテッド | Ocular implant and delivery system with pressure sensor |
US11925578B2 (en) | 2015-09-02 | 2024-03-12 | Glaukos Corporation | Drug delivery implants with bi-directional delivery capacity |
WO2017053885A1 (en) | 2015-09-25 | 2017-03-30 | Glaukos Corporation | Punctal implants with controlled drug delivery features and methods of using same |
WO2017106517A1 (en) | 2015-12-15 | 2017-06-22 | Ivantis, Inc. | Ocular implant and delivery system |
TW201722377A (en) * | 2015-12-16 | 2017-07-01 | 諾華公司 | Devices and methods for a cannula-delivered treatment material application device |
AU2017252294B2 (en) | 2016-04-20 | 2021-12-02 | Dose Medical Corporation | Bioresorbable ocular drug delivery device |
BR112018074389A2 (en) | 2016-06-02 | 2019-03-06 | Aquesys, Inc. | intraocular drug shipment |
EP3669836B1 (en) * | 2016-06-03 | 2021-08-04 | New World Medical, Inc. | Intraocular drainage device |
WO2019051475A1 (en) * | 2017-09-11 | 2019-03-14 | Oregon Health & Science University | Glaucoma tube implant with modulated flow |
US11246753B2 (en) | 2017-11-08 | 2022-02-15 | Aquesys, Inc. | Manually adjustable intraocular flow regulation |
US11135089B2 (en) | 2018-03-09 | 2021-10-05 | Aquesys, Inc. | Intraocular shunt inserter |
US10952898B2 (en) | 2018-03-09 | 2021-03-23 | Aquesys, Inc. | Intraocular shunt inserter |
CN108433748A (en) * | 2018-04-11 | 2018-08-24 | 中山大学中山眼科中心 | The harvester of liquid sample with valve |
US10369049B1 (en) | 2018-08-17 | 2019-08-06 | Iridex Corporation | Probes having fiber taper and fluid collection channel for ophthalmic laser treatment |
KR102390116B1 (en) * | 2019-11-19 | 2022-04-25 | 주식회사 마이크로트 | Implant device for lowering intraocular pressure with easy and safe method |
AU2022205382A1 (en) | 2021-01-11 | 2023-06-22 | Alcon Inc. | Systems and methods for viscoelastic delivery |
Family Cites Families (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4037604A (en) * | 1976-01-05 | 1977-07-26 | Newkirk John B | Artifical biological drainage device |
US4099529A (en) | 1976-09-20 | 1978-07-11 | Peyman Gholam A | Wide-angle cutter vitrophage |
US4521210A (en) | 1982-12-27 | 1985-06-04 | Wong Vernon G | Eye implant for relieving glaucoma, and device and method for use therewith |
US4634418A (en) * | 1984-04-06 | 1987-01-06 | Binder Perry S | Hydrogel seton |
US4604087A (en) | 1985-02-26 | 1986-08-05 | Joseph Neil H | Aqueous humor drainage device |
NZ215409A (en) | 1986-03-07 | 1989-02-24 | Anthony Christopher Be Molteno | Implant for drainage of aqueous humour in glaucoma |
US5071408A (en) * | 1988-10-07 | 1991-12-10 | Ahmed Abdul Mateen | Medical valve |
US4946436A (en) | 1989-11-17 | 1990-08-07 | Smith Stewart G | Pressure-relieving device and process for implanting |
US5041081A (en) | 1990-05-18 | 1991-08-20 | Odrich Ronald B | Ocular implant for controlling glaucoma |
US5476445A (en) * | 1990-05-31 | 1995-12-19 | Iovision, Inc. | Glaucoma implant with a temporary flow restricting seal |
US5454796A (en) | 1991-04-09 | 1995-10-03 | Hood Laboratories | Device and method for controlling intraocular fluid pressure |
US5171213A (en) | 1991-08-14 | 1992-12-15 | Price Jr Francis W | Technique for fistulization of the eye and an eye filtration prosthesis useful therefor |
US5346464A (en) * | 1992-03-10 | 1994-09-13 | Camras Carl B | Method and apparatus for reducing intraocular pressure |
US5342370A (en) | 1993-03-19 | 1994-08-30 | University Of Miami | Method and apparatus for implanting an artifical meshwork in glaucoma surgery |
FR2721499B1 (en) | 1994-06-22 | 1997-01-03 | Opsia | Trabeculectomy implant. |
US6102045A (en) | 1994-07-22 | 2000-08-15 | Premier Laser Systems, Inc. | Method and apparatus for lowering the intraocular pressure of an eye |
US5704907A (en) | 1994-07-22 | 1998-01-06 | Wound Healing Of Oklahoma | Method and apparatus for lowering the intraocular pressure of an eye |
US5601094A (en) * | 1994-11-22 | 1997-02-11 | Reiss; George R. | Ophthalmic shunt |
US5433701A (en) | 1994-12-21 | 1995-07-18 | Rubinstein; Mark H. | Apparatus for reducing ocular pressure |
US5558630A (en) | 1994-12-30 | 1996-09-24 | Fisher; Bret L. | Intrascleral implant and method for the regulation of intraocular pressure |
WO1996020742A1 (en) | 1995-01-06 | 1996-07-11 | Wong Vernon G | Improve eye implant for relief of glaucoma |
FR2747033B1 (en) | 1996-04-03 | 1998-05-22 | Parrat Michel Jesus Hubert | DYNAMIC MEATIC SHUTTER FOR LACRYMAL CANALICLES |
US6007510A (en) * | 1996-10-25 | 1999-12-28 | Anamed, Inc. | Implantable devices and methods for controlling the flow of fluids within the body |
US6142969A (en) * | 1996-10-25 | 2000-11-07 | Anamed, Inc. | Sutureless implantable device and method for treatment of glaucoma |
GB9700390D0 (en) | 1997-01-10 | 1997-02-26 | Biocompatibles Ltd | Device for use in the eye |
FR2759577B1 (en) | 1997-02-17 | 1999-08-06 | Corneal Ind | DEEP SCLERECTOMY IMPLANT |
US5882327A (en) | 1997-04-17 | 1999-03-16 | Jacob; Jean T. | Long-term glaucoma drainage implant |
US5752928A (en) * | 1997-07-14 | 1998-05-19 | Rdo Medical, Inc. | Glaucoma pressure regulator |
US6077299A (en) * | 1998-06-22 | 2000-06-20 | Eyetronic, Llc | Non-invasively adjustable valve implant for the drainage of aqueous humor in glaucoma |
AU767526B2 (en) * | 1999-04-26 | 2003-11-13 | Gmp Vision Solutions, Inc. | Trabeculotomy device and method for treating glaucoma |
US6589203B1 (en) * | 2000-01-26 | 2003-07-08 | Peter Mitrev | Glaucoma drainage device implant |
US7867186B2 (en) | 2002-04-08 | 2011-01-11 | Glaukos Corporation | Devices and methods for treatment of ocular disorders |
US6699211B2 (en) | 2000-08-22 | 2004-03-02 | James A. Savage | Method and apparatus for treatment of glaucoma |
CN100591372C (en) | 2002-07-19 | 2010-02-24 | 耶鲁大学 | Uveoscleral drainage device |
US7604647B2 (en) | 2004-10-22 | 2009-10-20 | Medical Instrument Development Laboratories, Inc. | Ophthalmic cannula insertion tool and method |
-
2003
- 2003-07-21 CN CN03822476A patent/CN100591372C/en not_active Expired - Fee Related
- 2003-07-21 US US10/624,882 patent/US7041077B2/en active Active
- 2003-07-21 AT AT03765883T patent/ATE419026T1/en not_active IP Right Cessation
- 2003-07-21 AU AU2003256657A patent/AU2003256657A1/en not_active Abandoned
- 2003-07-21 MX MXPA05000807A patent/MXPA05000807A/en active IP Right Grant
- 2003-07-21 CN CN201010003567A patent/CN101791258A/en active Pending
- 2003-07-21 CA CA2744117A patent/CA2744117A1/en not_active Abandoned
- 2003-07-21 AT AT08173090T patent/ATE550056T1/en active
- 2003-07-21 EP EP03765883A patent/EP1534363B1/en not_active Expired - Lifetime
- 2003-07-21 EP EP08173090A patent/EP2039380B1/en not_active Expired - Lifetime
- 2003-07-21 BR BRPI0312816-4A patent/BR0312816A/en not_active IP Right Cessation
- 2003-07-21 WO PCT/US2003/022832 patent/WO2004008945A2/en not_active Application Discontinuation
- 2003-07-21 EP EP10180135A patent/EP2286773B1/en not_active Expired - Lifetime
- 2003-07-21 ES ES03765883T patent/ES2320121T3/en not_active Expired - Lifetime
- 2003-07-21 CA CA2493010A patent/CA2493010C/en not_active Expired - Fee Related
- 2003-07-21 DE DE60325606T patent/DE60325606D1/en not_active Expired - Lifetime
-
2005
- 2005-02-18 ZA ZA200501458A patent/ZA200501458B/en unknown
-
2006
- 2006-03-13 US US11/374,398 patent/US7662123B2/en not_active Expired - Fee Related
- 2006-04-19 HK HK06104686.5A patent/HK1084313A1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP2039380A2 (en) | 2009-03-25 |
WO2004008945A3 (en) | 2005-02-03 |
WO2004008945A9 (en) | 2004-06-10 |
AU2003256657A8 (en) | 2004-02-09 |
ATE550056T1 (en) | 2012-04-15 |
EP1534363A4 (en) | 2006-09-13 |
EP1534363A2 (en) | 2005-06-01 |
AU2003256657A1 (en) | 2004-02-09 |
EP2286773A1 (en) | 2011-02-23 |
WO2004008945A2 (en) | 2004-01-29 |
HK1084313A1 (en) | 2006-07-28 |
BR0312816A (en) | 2007-06-26 |
CA2744117A1 (en) | 2004-01-29 |
MXPA05000807A (en) | 2005-06-17 |
CN101791258A (en) | 2010-08-04 |
EP2039380A3 (en) | 2011-02-23 |
CN100591372C (en) | 2010-02-24 |
ZA200501458B (en) | 2005-09-07 |
US20060155238A1 (en) | 2006-07-13 |
ATE419026T1 (en) | 2009-01-15 |
CN1684728A (en) | 2005-10-19 |
EP1534363B1 (en) | 2008-12-31 |
ES2320121T3 (en) | 2009-05-19 |
US7041077B2 (en) | 2006-05-09 |
US20040015140A1 (en) | 2004-01-22 |
DE60325606D1 (en) | 2009-02-12 |
CA2493010C (en) | 2011-09-13 |
EP2039380B1 (en) | 2012-03-21 |
US7662123B2 (en) | 2010-02-16 |
EP2286773B1 (en) | 2012-10-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2493010A1 (en) | Uveoscleral drainage device | |
US11504275B2 (en) | Methods and apparatus for treating glaucoma | |
US20240122755A1 (en) | Shunt system, shunt and method for treating an ocular disorder | |
US9351874B2 (en) | Methods and apparatus for delivering ocular implants into the eye | |
US8337509B2 (en) | Methods and apparatus for delivering ocular implants into the eye | |
US20060129129A1 (en) | Eye implant devices and method and device for implanting such devices for treatment of glaucoma | |
CA2153418C (en) | Method and apparatus for implanting an artificial meshwork in glaucoma surgery | |
JP2023014103A (en) | Ocular implant systems | |
JP2016052571A (en) | System for draining and supplying fluid | |
GB2296663A (en) | Drainage device for alleviating excess ophthalmic fluid pressure | |
US10952897B1 (en) | Eye implant devices and method and device for implanting such devices for treatment of glaucoma | |
CA2774610A1 (en) | Uveoscleral drainage device | |
US20210106462A1 (en) | Glaucoma drainage implant venting assembly | |
US11395764B1 (en) | Eye implant devices and method and device for implanting such devices for treatment of glaucoma | |
US10219942B1 (en) | Eye implant devices and method and device for implanting such devices for treatment of glaucoma | |
WO2023135549A1 (en) | Surgical kit and method for treating glaucoma |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |
Effective date: 20140722 |